|
|
|
||||||||||||||||||||
|
|
|
ABOUT PROMEDIOR: Investors
Promedior has raised a total of $41 million from leading global healthcare venture investors since its inception in 2006. Promedior’s investors include Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, Forbion Capital Partners and Easton Capital.
|
|
|
|
 |
|
|
|
|
|
Fibrosis is the fundamental common pathology behind many of the deadliest and most costly diseases worldwide. Treatment options for fibrotic diseases are limited, with no approved anti-fibrotic drugs in the US. |
|
|
|
|
|
|
|
|
|